Skip to content
Use caution Drug recall · FDA · Published September 11, 2014

Qualitest Recalls Methylprednisolone Tablets Due to Subpotency

Qualitest Pharmaceuticals recalls specific lots of Methylprednisolone Tablets USP 4 mg because they may be subpotent at the 6-month stability time point.

🇺🇸 FDA recall #D-1605-2014DrugQualitest Pharmaceuticals ›
Take action

Contact the company

Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer

Qualitest Pharmaceuticals is recalling specific lots of Methylprednisolone Tablets, USP 4 mg, because testing indicates they may be subpotent. This issue was identified during a 6-month stability time point evaluation. The recall affects both 100-count bottles and 21-count blister packs distributed nationwide. Read more at govinfonow.com/recall/45762-qualitest-pharmaceuticals-recalls-methylprednisolone-tablets-usp-4-mg-a-100.

Source Summary by GovInfoNow · govinfonow.com/recall/45762-qualitest-pharmaceuticals-recalls-methylprednisolone-tablets-usp-4-mg-a-100 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1605-2014

Cite this page

“Qualitest Recalls Methylprednisolone Tablets Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45762-qualitest-pharmaceuticals-recalls-methylprednisolone-tablets-usp-4-mg-a-100. Based on FDA recall #D-1605-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1605-2014%22&limit=1).

Qualitest Pharmaceuticals voluntarily recalled Methylprednisolone Tablets USP 4 mg due to subpotency issues, the Food and Drug Administration said on Sept. 11, 2014. The Class III recall affects 159,913 tablets distributed nationwide.

How to tell if you have it

  • Brand: Qualitest Pharmaceuticals
  • Product: Methylprednisolone Tablets USP 4 mg
  • NDC 0603-4593-21 (100 count bottles), Lot T147F13A, Exp. 05/2015
  • NDC 0603-4593-15 (21 count blister pack), Lot S003M14, Exp. 05/2015

The hazard

The tablets are subpotent at the six-month stability time point, according to the FDA recall record.

Context

GovInfoNow's records show Qualitest Pharmaceuticals has 12 other recalls on file since April 19, 2013. Other recent recalls of similar products include Allopurinol Tablets Recall (July 20, 2015), Hydroxyzine Tablets Recall (June 29, 2015), and Disulfiram 500mg Tablets Recall (June 18, 2015). Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Specialty Process Labs Thyroid Product Recall (Jan. 16, 2026), and Unichem busPIRone 5mg Tablets Recall (April 13, 2026) also involved subpotent drug risks.

How to tell if you have this one

Check your medication for the following details: Brand: Qualitest Pharmaceuticals. Product: Methylprednisolone Tablets, USP 4 mg. NDC/Package Types: 100 count bottles (NDC 0603-4593-21) or 21 count blister packs (NDC 0603-4593-15). Lot Numbers: T147F13A (Exp. 05/2015) for bottles, S003M14 (Exp. 05/2015) for blister packs.

  • Brand
    Qualitest Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Reach out to your pharmacy or healthcare provider immediately to discuss the recall and determine if you have affected lots.

  2. Verify Lot Numbers

    Check the lot numbers on your packaging against the recalled lots T147F13A and S003M14 to confirm if your medication is included in this recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Sep 11, 201412. FDA classified it Class III: Sep 22, 201423. Published in FDA’s Enforcement Report: Oct 1, 201434. FDA terminated the recall: Jan 27, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1605-2014 (September 11, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1605-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA